Sigyn Therapeutics, Inc. Sigyn Therapeutics, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Sigyn Therapy™
  • Oncology
    • Overview
    • ImmunePrep™
    • ChemoPrep™
    • ChemoPure™
  • News
    • Press Releases
    • Presentations
    • Resources
  • Media
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Email Alerts
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Contact
  • CEO Notes

Media

The Big Biz Show Part Two
Mar 18, 2025

The Big Biz Show Part Two

The Big Biz Show Part One
Mar 18, 2025

The Big Biz Show Part One

Force Family Office Fireside Chat With Zacks Healthcare Analyst
Feb 26, 2025

Force Family Office Fireside Chat With Zacks Healthcare Analyst

Emerging Growth Conference
Nov 1, 2024

Emerging Growth Conference

National Investment Bankers Association Conference
Sep 8, 2023

National Investment Bankers Association Conference

Sigyn Therapeutics outlines first-in-human clinical strategy for its novel blood purification technology
Oct 4, 2022

Sigyn Therapeutics outlines first-in-human clinical strategy for its novel blood purification technology

Sigyn Therapeutics Names Hepatology Leader Dr. Donald Hillebrand to SAB
Apr 26, 2022

Sigyn Therapeutics Names Hepatology Leader Dr. Donald Hillebrand to SAB

New Sigyn CFO Maps Nasdaq Uplist, Shelf Registration Strategy
Apr 7, 2022

New Sigyn CFO Maps Nasdaq Uplist, Shelf Registration Strategy

Sigyn Therapeutics Names Neurology Leader Dr. Ajay Verma to SAB
Mar 31, 2022

Sigyn Therapeutics Names Neurology Leader Dr. Ajay Verma to SAB

Cytokine Storm: The Unmet Need Sigyn Hopes To Address
Mar 30, 2022

Cytokine Storm: The Unmet Need Sigyn Hopes To Address

RSS
  • 1
  • 2
  • 3
  • Next
© 2025 Sigyn Therapeutics, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap